Clinical Trials Directory

Trials / Terminated

TerminatedNCT05778578

Universal Basic Income and Structural Racism in the US South

Universal Basic Income and Structural Racism in the US South: Differences in Health Service Utilization Between Older African American Men With and Without Experiences of Recent Incarceration

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
194 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
Male
Age
45 Years
Healthy volunteers
Not accepted

Summary

This Stage 3 efficacy study aims to address the critical need for interventions that increase access to appropriate community-based healthcare services, especially for those who have a history of incarceration and inform health policy by testing an intervention that directly reduces the racial income gap by providing a universal basic income (UBI). UBI is intended to promote and protect Black men's health through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. Participants will be split into 2 groups: the control and the intervention. Participants in the intervention group will be provided UBI of $500 per month for 6 months to increase healthcare utilization among chronically-ill, low-income Black men.

Detailed description

Structural racism and discrimination (SRD) are complex and drive racial inequities. SRD has sustained racial health disparities in the United States, driven disproportionate incarceration risk among Black men, and systematically restricted minority populations from health, wealth, and prosperity. As a result, diminished income earning ability for generations of Black people has led to economic devastation and poor health. Importantly, older and aging Black men continue to earn less than their White counterparts and the income gap is continuing to widen. Even when accounting for education, research has shown that the rising wage gap is attributable to workforce experience and opportunity, hiring and wage discrimination, and incarceration. Difficulty attaining prevailing wages among older Black men affects family stability, the ability for communities to thrive, and population health. Geography, place, and proximity to capital and markets are underlying drivers of health behavior and healthcare access. As a result, older and aging Black men in particular have demonstrated one of the strongest epidemiologic relationships between low socioeconomic status, residence in communities with endemic poverty, and chronic disease. The proposed Stage 3 efficacy study aims to test a novel intervention that directly reduces the racial income gap by providing a universal basic income (UBI). UBI is intended to promote and protect Black men's health through the influx of capital and subsequent increases in personal agency and social connections. We hypothesize that providing UBI of $500 per month for six months will result in increased healthcare utilization among chronically-ill, older and aging, low-income Black men. Secondarily, we hypothesize that the effect of UBI will depend on whether an individual has a recent history of incarceration, such that no incarceration history combined with UBI ill demonstrate the best study outcomes. Empirical research examining UBI among older Black men and its capacity to overturn SRD are lacking in the extant literature. Much of the health disparities research intended to inform health and economic policy originated from limited perspectives of older and aging Black men. Dr. W.E.B. Du Bois said in The Souls of Black Folk that for Black people, "discouragement is an unwritten word". This study draws on that inspiration as it ultimately seeks to fundamentally overturn the economic oppression and brutality that has defined the Black experience for generations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALUniversal Basic IncomeUniversal basic income (UBI) is a system that gives everyone a minimum amount of money regularly, regardless of their income or work status.

Timeline

Start date
2023-09-28
Primary completion
2025-03-13
Completion
2025-03-13
First posted
2023-03-21
Last updated
2025-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05778578. Inclusion in this directory is not an endorsement.